Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Return on Assets (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Return on Assets for 12 consecutive years, with 0.3% as the latest value for Q1 2026.

  • For Q1 2026, Return on Assets rose 5.0% year-over-year to 0.3%; the TTM value through Mar 2026 reached 0.3%, up 5.0%, while the annual FY2025 figure was 0.41%, 10.0% down from the prior year.
  • Return on Assets hit 0.3% in Q1 2026 for Wave Life Sciences, up from 0.46% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.24% in Q1 2024 and bottomed at 0.99% in Q4 2022.
  • Average Return on Assets over 5 years is 0.49%, with a median of 0.48% recorded in 2025.
  • Year-over-year, Return on Assets crashed -39bps in 2022 and then soared 74bps in 2023.
  • Wave Life Sciences' Return on Assets stood at 0.99% in 2022, then soared by 75bps to 0.24% in 2023, then fell by -13bps to 0.27% in 2024, then tumbled by -70bps to 0.46% in 2025, then soared by 35bps to 0.3% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.3%, 0.46%, and 0.49% for Q1 2026, Q4 2025, and Q3 2025 respectively.